Raed Dweik, MD, MBA, is the new Chairman of Cleveland Clinic’s Respiratory Institute. Get to know him and his plans for pulmonary medicine, critical care, infectious disease and allergy/immunology in this Q&A.Read More
The establishment of stratification, treatment guidelines and therapeutic response criteria should provide physicians with guidance in choosing appropriate therapies and assessing responses in this rare disease.
The integrated health approach delivered in the scope of IBD medical home reaches beyond the biological disease and captures 90 percent or more of the patient’s needs, whereas the standard approach that involves only a gastroenterologist has proven to only focus on the disease itself. GI Chairman Miguel Regueiro explains.
A 24-year-old female with progressive keratoconus and decreasing vision achieves improved vision with combined transepithelial phototherapeutic keratectomy and corneal crosslinking procedure.
PAD is often associated with atherosclerotic disease in other vascular beds, yet it’s widely underdiagnosed. We run through the symptoms and risk factors that should prompt PAD screening.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
The NCCN has introduced the nation’s first-ever guidelines for systemic mastocytosis, a rare, complex and sometimes aggressive hematologic disease.
As interest grows in the use of multiple modalities to monitor the neurocritically ill, optimal data integration and real-time data display are crucial. Here’s a glimpse of how we’re taking on the challenge.
Taking teamwork seriously — through frequent tumor board meetings, openness to new approaches and more — is essential to achieving three-star Society of Thoracic Surgeons composite quality ratings.
In this Q&A, Georges-Pascal Haber, MD, PhD, discusses his leadership style, the role of research and plans for the future.
In patients with newly diagnosed glioblastoma who aren’t candidates for resection, minimally invasive ablative treatment appears to be reasonable initial therapy, a new study suggests.